STAMBPL1

Across TCGA pan-cancer cohorts, STAMBPL1 RNA differs between tumor and matched normal tissue in 14 of 18 cancer types tested, making tumor–normal expression one of STAMBPL1’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where STAMBPL1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types STAMBPL1 is over-expressed in tumor, although a few such as BRCA and UCEC show the opposite, repressed pattern.

KIRC, HNSC, and STAD are the cancer types where STAMBPL1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in STAMBPL1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	Male	IV	+2.073	<.001	12	view →
HNSC	All	III,IV	+0.582	<.001	12	view →
STAD	Male	II,III,IV	+1.318	<.001	8	view →
COAD	Female	II,III,IV	+0.772	<.001	8	view →
LIHC	Male	All	+0.741	<.001	8	view →
LUAD	Male	All	+0.935	<.001	7	view →
KIRP	All	All	+0.528	<.001	6	view →
BRCA	Female	All	−0.268	<.001	4	view →
CHOL	All	All	+1.108	.001	3	view →
ESCA	All	II,III,IV	+1.580	.028	2	view →
READ	Female	All	+1.333	<.001	2	view →
UCEC	All	All	−0.444	.023	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 12 strongest of 14 lineages.

STAMBPL1–KIRC

Open the KIRC breakdown →